Lim Jonathan E Insider Trades

Insider Trading History

Track insider trading activity for Lim Jonathan E. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Erasca
Erasca ERAS
10% owner, Chairman & CEO
Holding Value $26.4M 2,000,000 shares
Last Trade
Jan 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.6M 2,000,000 shares
$10.31
$13.18
Boundless Bio
Boundless Bio BOLD
Director
Holding Value $34.6k 24,000 shares
Last Trade
Jun 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.7k 24,000 shares
$1.03
$1.44
Erasca
Erasca ERAS
10% owner, Chairman & CEO
Holding Value $33M 2,500,000 shares
Last Trade
Feb 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.4M 2,500,000 shares
$1.76
$13.18
Erasca
Erasca ERAS
10% owner, Chairman & CEO
Holding Value $8.34M 632,759 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.28M 632,759 shares
$2.03
$13.18
Erasca
Erasca ERAS
10% owner, Chairman & CEO
Holding Value $19.8M 1,500,000 shares
Last Trade
Feb 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.55M 1,500,000 shares
$1.70
$13.18
Erasca
Erasca ERAS
10% owner, Chairman & CEO
Holding Value $170M 12,899,360 shares
Last Trade
Dec 06, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$478k 278,150 shares
$1.72
$13.18
Erasca
Erasca ERAS
10% owner, Chairman & CEO
Holding Value $170M 12,899,360 shares
Last Trade
Dec 05, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.22M 721,850 shares
$1.69
$13.18
Erasca
Erasca ERAS
10% owner, Chairman & CEO
Holding Value $256M 19,456,216 shares
Last Trade
Oct 05, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.03M 1,000,000 shares
$2.03
$13.18
Erasca
Erasca ERAS
10% owner, Chairman & CEO
Holding Value $242M 18,396,216 shares
Last Trade
Jun 08, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$275k 100,000 shares
$2.75
$13.18
Erasca
Erasca ERAS
10% owner, Chairman & CEO
Holding Value $241M 18,296,216 shares
Last Trade
Mar 28, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$284k 100,000 shares
$2.84
$13.18
Erasca
Erasca ERAS
10% owner, Chairman & CEO
Holding Value $19.8M 1,500,000 shares
Last Trade
Feb 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6M 1,500,000 shares
$4.00
$13.18
Erasca
Erasca ERAS
Chairman & CEO
Holding Value $267M 20,256,222 shares
Last Trade
Jan 10, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$232k 60,000 shares
$3.86
$13.18
Erasca
Erasca ERAS
Chairman & CEO
Holding Value $266M 20,196,222 shares
Last Trade
Dec 14, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$200k 40,000 shares
$4.99
$13.18
Erasca
Erasca ERAS
Chairman & CEO
Holding Value $10.4M 791,000 shares
Last Trade
Feb 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.13M 791,000 shares
$11.54
$13.18
Prometheus Biosciences
Prometheus Biosciences RXDX
10% owner, President, CEO & Director
Holding Value $0 0 shares
Last Trade
Feb 08, 2018 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
No data
No data
$199.92
Prometheus Biosciences
Prometheus Biosciences RXDX
President, CEO And Director
Holding Value $35.9M 179,661 shares
Last Trade
Dec 26, 2017 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
No data
No data
$199.92
Prometheus Biosciences
Prometheus Biosciences RXDX
President, CEO & Director
Holding Value $39.7M 198,667 shares
Last Trade
Dec 22, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$199.92
Prometheus Biosciences
Prometheus Biosciences RXDX
10% owner, President, CEO & Director
Holding Value $26.1M 130,333 shares
Last Trade
Feb 13, 2017 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$199.92
Prometheus Biosciences
Prometheus Biosciences RXDX
10% owner, President, CEO & Director
Holding Value $0 0 shares
Last Trade
Feb 13, 2017 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$199.92
Prometheus Biosciences
Prometheus Biosciences RXDX
10% owner, President, CEO & Director
Holding Value $24M 120,000 shares
Last Trade
Jan 05, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$199.92

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up